Curriculum Vitae

Christopher J. Swearingen Curriculum Vitae

University of Arkansas for Medical SciencesDepartment of PediatricsBiostatistics, Slot 512-43 T (501) 364-66391 Children’s Way u (501) 364-1431Little Rock, AR 72202 B [email protected]

CONTACT

INFORMATION

Ph.D. – Biostatistics August 2009EDUCATION

Medical University of South Carolina, Charleston SC USA

M.S. – Biostatistics Decemeber 2006Medical University of South Carolina, Charleston SC USA

B.A. – Psychology (Double Minor - Math & German) May 1995Belmont University, Nashville TN USA

Senior Director, Biostatistics Aug 2014–PresentEMPLOYMENT

Samumed, San Diego, CA

Associate Professor Jul 2014–Jul 2014Department of Pediatrics, College of Medicine (Primary Appointment)Department of Genetics, College of Medicine (Secondary Appointment)University of Arkansas for Medical Sciences

Associate Director, Pediatric Biostatistics Program Aug 2012–Jul 2014Arkansas Children’s Hospital (ACH) Research Institute (ACHRI), Little Rock, AR

Assistant Professor (Secondary Appointment) Aug 2009–Jul 2014Department of Biostatistics, Fay W. Boozman College of Public HealthUniversity of Arkansas for Medical Sciences, Little Rock, AR

Assistant Professor Aug 2009–Jun 2014Department of Pediatrics, College of Medicine (Primary Appointment)Department of Genetics, College of Medicine (Secondary Appointment)University of Arkansas for Medical Sciences

Research Assistant 2004-2006Department of Biostatistics, Bioinformatics and EpidemiologyMedical University of South Carolina, Charleston, SC

Database Analyst 1995-2004Health Outcomes Research, Department of Rheumatology / ImmunologyVanderbilt University Medical Center, Nashville, TN

Last Updated: July 16, 2014 1 of 26

American Statistical Association (ASA) 2005–International Biometric Society, Eastern North American Region (ENAR) 2008–Institute of Mathematical Statistics (IMS) 2008–International Society for Bayesian Analysis (ISBA) 2008–

PROFESSIONAL

MEMBERSHIPS

ACH Victory Visions – “Crossing the Creek” Oct–2011ASA Consulting Section Joint Statistical Meeting Travel Award Aug–2011Best Contributed Paper Statistics and Data Analysis – SAS Global Forum Apr–2011University of Arkansas for Medical Sciences Teaching Scholar 2009–2011ACH Victory Visions – “Teamwork” Sep–2010MD Anderson Bayesian Biostatistics Conference Travel Award Jan–2009NIH/NINDS Biostatistics Training with Application to Neuroscience 2006–2009Medical University of South Carolina Presidential Scholar Fellow 2007–2008Medical University of South Carolina Presidential Scholar 2006–2007

HONORS AND

AWARDS

American Statistical Association (ASA)

Assistant Newsletter Editor, ASA Statistical Consulting Section Jul 2014–Present

Chair, Contributed Session at Joint Statistical Meeting (JSM) 2012 30 Jul-2012“Contributed Oral Poster Presentations: Section on Statistical Consulting”

Organizer, Topic-Contributed Session at JSM 2011 2 Aug-2011“Perspectives on Reproducible Research: Moving from Buzzword to Doctrine”

Newsletter Editor, ASA Statistical Consulting Section Jul 2011–Jun 2014

President, Central Arkansas ASA Chapter 2011

Vice-President, Central Arkansas ASA Chapter 2010

SERVICE

(PROFESSIONAL)

International Biometric Society, Eastern North American Region (ENAR)

Chair, Contributed Session at ENAR 2010 24 March–2010“Methods for Combining Matched & Unmatched Case-Control Studies”

College of Medicine, University of Arkansas for Medical Sciences

Interviewer, Medical School Applicants 8 January–2011Interviewer, Medical School Applicants 9 January–2010Interviewer, Medical School Applicants 31 October–2009

SERVICE

(INSTITUTION)

Graduate School, University of Arkansas for Medical Sciences

Judge, Poster Session for Student Research Week 21 April–2010

Last Updated: July 16, 2014 2 of 26

Department of Pediatrics, University of Arkansas for Medical Sciences

Judge, Poster Session for Fellow’s Day 14 May–2013Judge, Poster Session for Fellow’s Day 15 May–2012Educational Scholarship Working Group (ESWOG) 2010–2011

Pediatric Biostatistics Program, University of Arkansas for Medical Sciences

Chair, Faculty Biostatistician Search Committee 2012–PresentChair, Faculty Statistical Geneticist Search Committee 2012Chair, Database Administration Manager Search Committee 2012Member, Staff Biostatistician Search Committee 2012Member, Business Officer Search Committee 2012Member, Faculty Biostatistician Search Committee 2010Member, Staff Biostatistician Search Committee 2010Manager, Program Website 2010–PresentInterim Director (as needed) 2010–2012

Continuing Education

Central Arkansas Statistical Association Short Course 19 Apr–2013“Logistic Regression”

UAMS Department of Pediatrics 12 Mar–2013“Birkman Leadership Styles Workshop”

UAMS Department of Pediatrics 2011–2012“Faculty Development Leadership Institute”

UAMS Department of Pediatrics 10 Nov–2011“21st Annual Professional Development Day”

Vanderbilt Biostatistics Short Course 9-11 March–2011“Regression Modeling Strategies”

UAMS Pediatric Biostatistics Workshop 19-20 Jan–2010“Sample Size Analysis in Study Planning: Concepts and Issues”

Central Arkansas Statistical Association Short Course 13 Nov–2009“Introduction to Meta-Analysis”

OTHER

PROFESSIONAL

ACTIVITIES

Last Updated: July 16, 2014 3 of 26

National Institiute of Health

National Institute of Digestive and Diabetes and Kidney Diseases (NIDDK)

• Ad-Hoc Panel Review Member ZDK1 GRB-9 (O4) Jun–2014

• Ad-Hoc Panel Review Member ZDK1 GRB-9 (O2) Jun–2014

• Ad-Hoc Panel Review Member ZDK1 GRB-9 (M5) Apr–2014

• Ad-Hoc Panel Review Member ZDK1 GRB-9 (M3) Apr–2014

• Ad-Hoc Panel Review Member ZDK1 GRB-9 (M4) Mar–2014

• Ad-Hoc Panel Review Member ZDK1 GRB-9 (M2) Mar–2014

• Ad-Hoc Panel Review Member ZDK1 GRB 9 (J2) Nov–2013

• Ad-Hoc Panel Review Member ZDK1 GRB-9 (J3) Oct–2013

• Ad-Hoc Panel Review Member ZDK1 GRB-9 (J1) Oct–2013

• Panel Review Member Apr–2013George M. O’Brien Urology Cooperative Research Centers Program

Journal Reviewer

Autoimmune Diseases 2013Applied Mathematics and Computation 2013Journal of Clinical Psychology in Medical Settings 2013Postgraduate Medical Journal 2012Journal of Pediatric Neurology 2012Journal of Clinical Psychology in Medical Settings 2011Journal of Clinical Rheumatology & Musculoskeletal Medicine 2010

Editorial Board

Advances in Medicine: Epidemiology section 2013

Last Updated: July 16, 2014 4 of 26

Mentoring

Kent Thompson May 2014– Jul 2014Role: Mentor UAMS College of Public Health Preceptorship

Andrea Sutton Jul 2013– Dec 2013Role: Co-Mentor UAMS College of Public Health Preceptorship

Paige Fisher Jun 2013– Sep 2013Role: Co-Mentor Pediatric Biostatistics Summer Intern

Maggie Beetstra Jun 2012– Aug 2012Role: Primary Mentor Pediatric Biostatistics Summer Intern

Maggie Beetstra Jun 2011– Jul 2011Role: Primary Mentor ACHRI Summer Science Program

Mallik Rettiganti Jun 2010– Sep 2010Role: Co-Mentor Pediatric Biostatistics Summer Intern

Elizabeth Calloway, ACH Clinical Nutrition Dietitian Spring 2010– Fall 2010Role: Statistics Mentor MS Human Nutrition, University of Alabama, Dec 2010

Andrea Muffuletto Jun 2010– Jul 2010Role: Statistics Mentor ACHRI Summer Science Program

Emily Spillyards, ACH Clinical Nutrition Dietitian Fall 2009–Spring 2010Role: Statistics Mentor MS Human Nutrition, University of Alabama, May 2010

TEACHING

Classroom Teaching

Faculty Development Seminar Research Series Fall 2010–Spring 2011

• Expanded the Basic Biostatistics Box Lunch “3B” Seminar Series to Seven MonthlyLectures:. Study Design and Conduct . Sample Size. Analysis of Categorical Data . Continuous Data Analysis. Linear Regression and ANOVA . Advanced Regression. Survival Analysis

• CME credit offered through Pediatric Education office• Supplemental Material and Video archived on UAMS Blackboard Intranet

Basic Biostatistics Box Lunch “3B” Seminar Series Spring 2010

• Developed and Implemented a Biostatistic lecture series for UAMS Pediatrics,Arkansas Children’s Hospital and Research Institute Faculty, Staff and trainees

• Lectures included:. Sample Size Determination . Grant Development. Understanding Diagnostic Test Results . Choosing a Statistical Test

Last Updated: July 16, 2014 5 of 26

Continuing Education Presentations / Seminars

ACHRI Summer Science Seminar 4 June–2013“Everything You Wanted To Know About Biostatistics. . . but were afraid to ask!”

UAMS Pediatric Biostatistics Training Seminar 5 April–2013“Empirical Sample Size Determination using Simulation”

Pediatric Cardiology Inservice 19 Feb–2013“REDCap Data Entry Tutorial”

Pediatric Cardiology Conference 7 Jan–2013“Setup and Management of Study Data using REDCap:”

“A Demonstation”

Pediatric Cardiology Conference 9 July–2012“Data Management 101:”

“The Good, the Bad, and the Excel Workbooks”

UAMS HeadStart Training 6 March–2012“Inservice - Using REDCap for HeadStart Assessment Data Management”

Pediatric Cardiology Conference 20 June–2011“Propensity Score Matching”

Health Research, Policy and Health Promotion Conference 17 May–2011“Translational and Reproducible Research:

Considerations and Challenges Facing Today’s Statistician”

UAMS Pediatric Biostatistics Research In Progress Seminar 11 May–2011“Reproducible Research”

Pediatric Cardiology Conference 2 May–2011“Reproducible Research”

REDCap Consortium Webinar 11 Feb–2011“Volunteer autism registry using REDCap Survey”

ACHRI Intramural Grant Seminar 19 Jan–2011“Statistical Considerations for CUMG Submission”

UAMS Pediatric Fellows Education Conference 9 Dec–2010“Knowing Which Test To Use”

REDCap Consortium Webinar 24 Sep–2010“Lessons learned supporting educational and research projects using REDCap”

ACHRI Intramural Grant Seminar 29 June–2010

Last Updated: July 16, 2014 6 of 26

“Statistical Considerations for CUMG Submission”

UAMS Pediatric Biostatistics Training Seminar 15 June–2010“Beta Regression Tutorial”

ACHRI Summer Science Seminar 7 June–2010“Everything You Wanted To Know About Biostatistics. . . but were afraid to ask!”

Current

USDA/AFRI 2010-04682 Weber (PI) 4/1/2011 – 7/31/2015Arkansas Grow Healthy StudyRole: Co-Investigator (0.6-1.2 calendar) $4,776,312

EXTRAMURAL

FUNDING (PEER-REVIEWED)

NIH/NIDDK STTR 2R42DK079387-03 James (PI) 9/1/2012 – 7/31/2014Adduct Dipstick for Diagnosis of Acetaminophen ToxicityRole: Co-Investigator (0.6 calendar) $389,762

Awarded

NIH PAR-11-242 Aitken (PI) 7/1/2014 – 6/30/2019Generations In Families Talking Safe Sleep (GIFTSS)Role: Co-Investigator (1.2 calendar) $2,403,411

Prior / Completed

NIH 1 UL1 RR029884 Lowery (PI) 1/1/2010 – 3/31/2014UAMS Translational Research InstitiuteRole: Pediatric Statistician (0.6-1.56 calendar) $19,900,000

USDA/AFRI 58-6251-8039 Weber (PI) 1/1/2012 – 9/30/2013Delta Garden StudyRole: Faculty Statistician (0.6 calendar) $2,356,550

NIH 1 R21 ESO17311-01A2 Blossom (PI) 1/1/2011 – 08/31/2012Neuroimmune Dysregulation with Trichloroethylene ExposureRole: Co-Investigator (0.6 calendar) $404,120

CDC 5 R49 CE00975-3 Aitken (PI) 7/1/2010 – 2/18/2011‘Strike-Out’ Child Passenger Injury PreventionRole: Faculty Statistician (0.36 calendar) $249,995

NIH/NINDS 1 T32NS 4800701A1 Palesch (PI) 8/1/2006 – 7/31/2009Biostatistics Training with Application to NeuroscienceRole: Pre-Doctoral Trainee $620,000

Last Updated: July 16, 2014 7 of 26

Current

Arkansas Department of Human Services Schaefer (PI) 9/1/2009 – 6/30/2014ANGELS – Newborn ScreeningRole: Faculty Statistician (1.2 calendar) $5,127,091

EXTRAMURAL

FUNDING

(CONTRACTUAL)

New York University Rheumatology Swearingen (PI) 3/1/2010 – 6/30/2014Rheumatic Disease Surveillance and Health OutcomesRole: PI of Contract (1.8 calendar) $224,872

Current

ACHRI / ABI # 037025 Swearingen (PI) Awarded – 9/5/2012Biostatistics Core Support — High Performance Computing ClusterRole: Principal Investigator $65,657

INTRAMURAL

FUNDING (PEER-REVIEWED)

Prior / Completed

UAMS TRI Community Pilot Award Swearingen (Co-PI) 6/1/2012 – 3/30/2014Development and Testing of a Mobile Electronic Data and Information Capture

Infrastructure: The MEDIC ProjectRole: Co-PI (Judith L. Weber Co-PI) (0.6 calendar) $76,598

ACHRI/ABI Weber (PI) 09/15/2013 – 12/31/2013ACHRI Childhood Obesity Prevention Research Program — Bridging RequestRole: Co-Investigator (0.6 calendar) $119,834

NIH CTN P20 GM103425 Mulkey (PI) 6/1/2012 – 5/31/2014Biomarkers Predicting Early Brain Injury in Neonatal Congenital Heart DiseaseRole: Co-Investigator (0.6 calendar) $150,000

ACHRI/ABI Mulkey (PI) 1/1/2011 – 5/31/2014Pediatric Neurology Project SupportRole: Faculty Statistician (0.6 calendar)

UAMS TRI KL2 Career Development Redwine (PI) 8/1/2011 – 7/31/2013Cardiovascular Risk Factor Surveillance Systems in Arkansas YouthRole: Statistical Advisor

ACHI Statistical OversightArkansas Center for Health Improvement Thompson (PI) 3/1/2011 – 6/30/2013Role: Statistician (as needed)

ACHRI CUMG Mulkey (PI) 6/1/2011 – 5/31/2013Brain MRI in Neonatal Hypoxic-Ischemic EncephalopathyRole: Co-Investigator $24,201

Last Updated: July 16, 2014 8 of 26

ACHRI CUMG Reeves (PI) 6/1/2011 – 5/31/2013ECHO Parameters Associated with Non-surgical Ductal Closure in Low Birth Weight InfantsRole: Co-Investigator $10,000

ACHRI Student/Staff Grant Irby (PI) 7/1/2011 – 6/30/2012Anti-Factor Xa Prediction of ECMO Circuit ChangeRole: Co-Investigator $2,000

ACHRI Student/Staff Grant Street (PI) 7/1/2011 – 6/30/2012Enteral Feeding Algorithm Implementation in the CVICURole: Co-Investigator $2,000

ACHRI CUMG Pasala (PI) 12/1/2010 – 11/31/2012Multimeric Patterns of Plasma von Willebrand Factor in Pediatric ECMO PatientsRole: Co-Investigator $20,000

ACHRI CUMG Perez Fournier (PI) 12/1/2010 – 11/31/2012Prophylactic Surfactant Administration with Rapid ExtubationRole: Co-Investigator $20,000

Arkansas Biosciences Institute1 Com (PI) 1/1/2011 – 12/31/2012Fat Free mass Index and Health Status in Pediatric Cystic FibrosisRole: Co-Investigator (0.6 calendar) $50,668

UAMS CCTR Rainmaker Pilot Grant Redwine (PI) 7/1/2010 – 6/30/2011Cardiovascular Risk Factor Surveillance Systems in Arkansas YouthRole: Co-Investigator (0.6 calendar) $50,000

PEER-REVIEWED

PUBLICATIONS [51] Jeffs D, Dorman D, Brown S, Files A, Graves T, Kirk E, Meredith-Neve S, Sanders J, White B,and Swearingen CJ. Effect of virtual reality on adolescent pain during burn wound care. JBurn Care Res 2014; EPUB.

[50] Mireles-Cabodevila RL, E.and Chatburn, Thruman T, Zabala LM, Holt S, Swearingen CJ,and Heulitt M. Mid-frequency ventilation (MFV): Proof of concept in an animal model. RespirCare 2014; EPUB.

[49] Pasala S, Fiser RT, Stine KC, Swearingen CJ, and Prodhan P. von Willebrand FactorMultimers in Pediatric Extracorporeal Membrane Oxygenation Support. ASAIO Journal2014; 60(4):419–423. http://goo.gl/0G0sUl.

[48] Stein KC, Wahl EC, Liu L, Skinner RA, Schilden JV, Bunn RC, Montgomery CO, Suva LJ,Aronson J, Becton DL, Nicholas RW, Swearingen CJ, and Lumpkin CK. Cisplatin inhibitsbone healing during distraction osteogenesis. J Orthop Res 2014; 32(3):464–470.http://goo.gl/dJC8f1.

[47] 2Mulkey SB and Swearingen CJ. Advancing neurologic care in the neonatal intensive careunit with a neonatal neurologist. J Child Neurol 2014; 29(1):31–35. http://goo.gl/wAbew.

[46] Mulkey SB, Swearingen CJ, Melguizo MS, Schmitz M, Ou X, Ramakrishnaiah RH,Glasier CM, Schaefer GB, and Bhutta AT. Multi-tiered analysis of brain injury in neonateswith congenital heart disease. Pediatr Cardiol 2014; 35:344–352. http://goo.gl/o4WkS.

1Transferred to another Faculty Statistician after exceeding required effort level.2Selected as ACHRI President’s Choice Publication – http://goo.gl/yHsw8

Last Updated: July 16, 2014 9 of 26

[45] Byrnes JB, Swearingen CJ, Prodhan P, Fiser RT, and Dyamenahalli U. Antithrombin IIIsupplementation on Extracorporeal Membrane Oxygenation: Impact on heparin dose andcircuit life. ASAIO Journal 2014; 60(1):57–62.

[44] Wyrick DL, Bozeman AP, Dassinger MS, Jackson RJ, Maxson RT, Kelley KR, Mathews DL,Li J, Swearingen CJ, and Smith SD. Persistent Gastrocutaneous Fistula: Factors affectingneed for closure. J Pediatr Surg 2013; 48(12):2506–2510.

[43] Mulkey SB, Swearingen CJ, Melguizo MS, Reeves RN, Rowell JA, Gibson N, Holland G,Bhutta AT, and Kaiser JR. Academic proficiency in children after early congenital heartdisease surgery. Pediatr Cardiol 2013; 34:1772–1784. http://goo.gl/T97jra.

[42] Aitken ME, Miller BK, Anderson BL, Swearingen CJ, Monroe KW, Daniels D, O’Neill J,Scherer LR, Hafner JW, and Mullins SH. Promoting use of booster seats in rural areasthrough community sports programs. J Rural Health 2013; 29:s70–s78.http://goo.gl/hBnZY.

[41] Dodgen AL, Dodgen AC, Swearingen CJ, Gossett JM, Dasgupta R, Butt W, Deshpande JK,and Gupta P. Characteristics and hemodynamic effects of extubation failure in childrenundergoing complete repair of tetralogy of fallot. Pediatr Cardiol 2013; 34(6):1455–1462.http://goo.gl/rjsId.

[40] Blossom SJ, Melnyk SB, Rau JL, Swearingen CJ, Cooney CA, and Wessinger WD.Metabolic changes and DNA hypomethylation in cerebellum are associated with behavioralalterations in mice exposed to trichloroethylene postnatally. Toxicol Appl Pharmacol 2013;269(3):269–269. http://goo.gl/1aifR.

[39] Kobayashi T, Kishimoto M, Swearingen CJ, Filopoulus MT, Ohara Y, Tokuda Y, Oshikawa H,Yoshida K, Utsunomiya M, Kimura M, Matsui K, and Yazici Y. Differences in clinicalmanifestations, treatment, and concordance rates with two major sets of criteria for Behçet’ssyndrome for patients in the US and Japan: data from a large, three-center cohort study.Mod Rheumatol 2013; 23(3):547–553. http://goo.gl/sVDxr.

[38] McCarty HM, Tang X, Swearingen CJ, and Collins II RT. Comparison of theelectrocardiographic QTc duration in patients with supravalvar aortic stenosis with-vs-withoutWilliams syndrome. Am J Cardiol 2013; 111(10):1501–1504. http://goo.gl/dmtDT.

[37] Uppu SC, Dyamenahalli U, Sachdeva R, Imamura M, Morrow WR, Gossett J,Swearingen CJ, and Vyas HV. Conal septal morphometrics can identify higher-riskneonates with Tetralogy of Fallot. J Am Soc Echocardiogr 2013; 26(2):200–207.http://goo.gl/opNCY.

[36] Sachdeva R, Frazier EA, Jaquiss RDB, Imamura M, Swearingen CJ, and Vyas HV.Echocardiographic evaluation of ventricular assist devices in pediatric patients. J Am SocEchocardiogr 2013; 26(1):41–49. http://goo.gl/BAFYV.

[35] Brown CM, Lloyd EC, Swearingen CJ, and Boateng BA. Improving resident self-efficacy inpediatric palliative care through clinical simulation. J Palliat Care 2012; 28(3):157–163.http://goo.gl/3C1DN.

[34] Kennish L, Labitigan M, Budoff S, Filopoulus MT, McCracken WA, Swearingen CJ, andYazici Y. Utility of the new rheumatoid arthritis 2010 ACR/EULAR classification criteria inroutine clinical care: A cohort study. BMJ Open 2012; 2:e001117. http://goo.gl/d5nio.

[33] Canon S, Basham K, Purifoy JA, and Swearingen C. Alternative approaches to expandingpediatric urology services and productivity. J Urology 2012; 188(4 Suppl):1639–1642.http://goo.gl/VhvvD.

[32] Garcia X, Kane J, Prodhan P, Bhutta A, Swearingen CJ, and Sachdeva R. A model forproviding improved care to chronic patients in cardiac intensive care unit. Congenit HeartDis 2012; 7(5):403–409. http://goo.gl/LEu8t.

Last Updated: July 16, 2014 10 of 26

[31] 3Mulkey SB, Yap VL, Swearingen CJ, Riggins MS, Kaiser JK, and Schaefer GB. Quantitivecranial magnetic resonance imaging in neonatal hypoxic-ischemic encephalopathy. PediatrNeurol 2012; 47(2):101–108. http://goo.gl/g1ojB.

[30] Knecht KR, Alexander ML, Swearingen CJ, and Frazier EA. NTproBNP as a marker ofrejection in pediatric heart transplant recipients. Pediatr Transplant 2012; 16(4):335–339.http://goo.gl/pwGyO.

[29] 4Bhutta AT, Schmitz ML, Swearingen C, James LP, Ward-Begnoche WL, Lindquist DM,Glasier CM, Tuzcu V, Prodhan P, Dyamenahalli U, Imamura M, Jaquiss RDB, andAnand KJS. Ketamine as a neuroprotective and anti-inflammatory agent in childrenundergoing surgery on cardiopulmonary bypass: A pilot randomized, doubleblindplacebo-controlled trial. Pediatr Crit Care Med 2012; 13(3):328–337.http://goo.gl/9ab01.

[28] Gibbons T, Frem J, Patil S, Smith C, Wakwe J, and Swearingen CJ. Non IgE-mediated cowmilk allergy is linked to early childhood clusters of commonly seen illnesses: A pilot study.Clinical Pediatrics 2012; 51(4):337–344. http://goo.gl/NLfgD.

[27] Collins RT II, Aziz PF, Swearingen CJ, and Kaplan PB. Relation of ventricular ectopiccomplexes to the QTc internal on ambulatory electrocardiograms in Williams Syndrome. AmJ Cardiol 2012; 109(11):1671–1676. http://goo.gl/eMP9u.

[26] Collins RT II, Gossett JM, and Swearingen CJ. Long-term survival of patients with restingobstructive hypertrophic cardiomyopathy: More questions than answers. J Am Coll Cardiol2012; 59:1730. http://goo.gl/TAk5k.

[25] Seidel SE, Tilley BC, Huang P, Palesch YY, Bergmann KJ, Goetz CG, and Swearingen CJ5

on behalf of the NET-PD Investigators. Subject-Investigator reproducibility of the UnifiedParkinson’s Disease Rating Scale. Parkinson Relat Disord 2012; 18(3):230–233.http://goo.gl/koMIZ.

[24] Brown C, Gephardt G, Lloyd C, Swearingen C, and Boateng B. Teaching palliative care skillsusing simulated family encounters. MedEdPORTAL 2011; 8507. http://goo.gl/AYGBb.

[23] 6Swearingen CJ, Tilley BC, Adams RJ, Rumboldt Z, Nicholas JS, Bandyopadhyay D, andWoolson RF. Application of beta regression to analyze ischemic stroke volume in NINDSrt-PA clinical trials. Neuroepidemiology 2011; 37(2):73–82. http://goo.gl/CZAyl.

[22] Byrnes J, McKamie W, Swearingen CJ, Gossett J, Prodhan P, Bhutta A, Chipman C,Jaquiss R, Imamura M, and Fiser R. Hemolysis during cardiac extracorporeal membraneoxygenation: A case-control comparison of roller pumps and centrifugal pumps in a pediatricpopulation. ASAIO Journal 2011; 57(5):456–461. http://goo.gl/Hfcdq.

[21] 7Thrailkill KM, Moreau CS, Swearingen CJ, Rettiganti MR, Edwards K, Morales AE,Kemp SF, Frindik JP, and Fowlkes JL. Insulin pump therapy started at the time of diagnosis:Effects on glycemic control and pancreatic beta cell function. Diabetes Technol Ther 2011;13(10):1023–1030. http://goo.gl/Q0BDB.

[20] Howard RG, Pillinger MH, Gyftopoulos S, Theile R, Swearingen CJ, and Samuels J.Reproducibility of musculoskeletal ultrasound for determining monosodium urate deposition:Concordance between readers. Arthritis Care Res 2011; 63(10):1456–1462.http://goo.gl/X5XY2.

[19] Garcia X, Jaquiss RDB, Srinivasan C, Imamura M, Swearingen C, Dassinger MS, andSachdeva R. Preemptive gastrostomy tube placement after Norwood Operation isassociated with improved survival to Stage 2 Palliation but more gastrointestinalcomplications. J Pediatrics 2011; 159(4):602–607. http://goo.gl/9pHrQ.

3Selected as ACHRI President’s Choice Publication — http://goo.gl/TrNYK4Selected as ACHRI President’s Choice Publication – http://goo.gl/1K8k35Corresponding Author6Selected as ACHRI President’s Choice Publication – http://goo.gl/N5mE87Selected as ACHRI President’s Choice Publication – http://goo.gl/xW6Qq

Last Updated: July 16, 2014 11 of 26

[18] Canon S, Purifoy J, Heulitt G, Hogan WR, Swearingen C, Williams MA, Alpert SA, andD Young. Pediatric urology survey of electronic medical records: Usage and perspectives. JUrology 2011; 186:1740–1745. http://goo.gl/h6ttz.

[17] Swearingen CJ, McCollum L, Daltroy LH, Pincus T, Dewalt DA, and Davis T. Screening forlow literacy in a rheumatology setting: More than 10% of patients cannot read“Cartilage,”“Diagnosis,” “Rheumatologist,” or “Symptom”. J Clin Rheumatol 2010;16(8):359–364. http://goo.gl/3EbND.

[16] Swigris JJ, Yorke J, Sprunger DB, Swearingen C, Pincus T, du Bois RM, Brown KK, andFischer A. Assessing dyspnea and its impact on patients with connective tissuedisease-related interstitial lung disease. Respiratory Med 2010; 104(9):1350–1355.http://goo.gl/NRBmd.

[15] Pincus T, Swearingen CJ, Bergman MJ, Colglazier CL, Kaell AT, Kunath AM, Siegel EL, andYazici Y. RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ(Multidimensional Health Assessment Questionnaire): Agreement with DAS28 (DiseaseActivity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in fiveversus more than ninety seconds. Arthritis Care Res 2010; 62(2):181–189.http://goo.gl/bL2uq.

[14] Swearingen AM, Loftus T, Ghaemmaghami V, Swearingen CJ, Salisbury H, Gerkin RD, andFerrara J. Extreme blood alcohol level is associated with increased reasouse use in traumapatients. American Surgeon 2010; 76(1):20–24. http://goo.gl/QXbo.

[13] Ravina B, Swearingen C, Elm J, Kamp C, Kieburtz K, and Kim SYH. Long termunderstanding of study information in research participants with Parkinson’s disease.Parkinsonism Relat Disord 2010; 16(1):60–63. http://goo.gl/qFXQZ.

[12] Pincus T, Swearingen CJ, Luta G, and Sokka T. Efficacy of 1-4 mg per day of prednisone inpatients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled withdrawalclinical trial. Ann Rheum Dis 2009; 68:1715–1720. http://goo.gl/vDQXz.

[11] Parashos SA, Swearingen CJ, Biglan KM, Bodis-Wollner I, Liang GS, Ross GW, Tilley BC,and Shulman LM. Determinants of the timing of symptomatic treatment in early Parkinsondisease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD)experience. Arch Neurol 2009; 66(9):1099–1104. http://goo.gl/Lgf2T.

[10] Nicholas JS, Swearingen CJ, and Kilmer JB. Predictors of skin cancer in commercial airlinepilots. Occupational Med 2009; 59(6):434–436. http://goo.gl/gHQ7b.

[9] Schneider MG, Swearingen CJ, Shulman LM, Ye J, Baumgarten M, and Tilley BC. Minorityenrollment in Parkinson’s disease clinical trials. Parkinsonism Relat Disord 2009;15(4):258–262. http://goo.gl/OeyNO.

[8] Pincus T, Swearingen CJ, Bergman M, and Yazici Y. RAPID3 (Routine Assessment ofPatient Index Data 3), a rheumatoid arthritis index without formal joint counts for routinecare: proposed severity categories compared to disease activity score and clinical diseaseactivity index categories. J Rheumatol 2008; 35(11):2136–2147. http://goo.gl/lAlYp.

[7] Pincus T, Bergman M, Sokka T, Roth J, Swearingen C, and Yazici Y. Visual analog scales informats other than a 10 centimeter horizontal line to assess pain and other clinical data. JRheumatol 2008; 35(8):1550–1558. http://goo.gl/4CiIL.

[6] Simon DK, Swearingen CJ, Hauser RA, Trugman JM, Aminoff MJ, Singer C, Truong D, andTilley BC on behalf of NET-PD Investigators. Caffeine and progression of Parkinson disease.Clin Neuropharmacol 2008; 31(4):189–196. http://goo.gl/weQ33.

[5] Nicholas JS, Swearingen CJ, Thomas JC, Rumboldt Z, Tumminello P, and Patel SJ. Theeffect of statin pretreatment on infarct volume in ischemic stroke. Neuroepidemiology 2008;31(1):48–56. http://goo.gl/cckiX.

Last Updated: July 16, 2014 12 of 26

[4] Keenan RT, Swearingen CJ, and Yazici Y. Erythrocyte sedimentation rate and c-reactiveprotein levels are poorly correlated with clinical measures of disease activity in rheumatoidarthritis, systemic lupus erythematosus and osteoarthritis patients. Clin Exp Rheumatol2008; 26(5):814–819. http://goo.gl/xXStn.

[3] Yazici Y, Sokka T, Kautiainen H, Swearingen C, Kulman I, and Pincus T. Long term safety ofmethotrexate in routine clinical care: discontinuation is unusual and rarely the result oflaboratory abnormalities. Ann Rheum Dis 2005; 64(2):207–211. http://goo.gl/aqQNq.

[2] Pincus T, Swearingen C, Cummins P, and Callahan LF. Preference for nonsteroidalantiinflammatory drugs versus acetaminophen and concomitant use of both types of drugs inpatients with osteoarthritis. J Rheumatol 2000; 27(4):1020–1027. http://goo.gl/wL1O2.

[1] Pincus T, Swearingen C, and Wolfe F. Toward a multidimensional health assessmentquestionnaire (MDHAQ): assessment of advanced activities of daily living and psychologicalstatus in the patient-friendly health assessment questionnaire format. Arthritis Rheum 1999;42(10):2220–2230. http://goo.gl/ZerfX.

AFFILIATED

PUBLICATIONS [7] Jawaheer D, Olsen J, Lahiff M, Forsberg S, Lähteenmäki J, da Silveira IG, Rocha FA,Magalhães Laurindo IM, Henrique da Mota LM, Drosos AA, Murphy E, Sheehy C, Quirke E,Cutolo M, Rexhepi S, Dadoniene J, Verstappen SM, and Sokka T for QUEST-RA. Gender,body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA Study.Clin Exp Rheumatol 2010; 28(4):454–461. http://goo.gl/LRHMc.

[6] Sokka T, Kautiainen H, Pincus T, Verstappen SM, Aggarwal A, Alten R, Andersone D,Badsha H, Baecklund E, Belmonte M, Craig-Müller J, da Mota LM, Dimic A, Fathi NA,Ferraccioli G, Fukuda W, Géher P, Gogus F, Hajjaj-Hassouni N, Hamoud H, Haugeberg G,Henrohn D, Hørslev-Petersen K, Ionescu R, Karateew D, Kuuse R, Laurindo IM, Lazovskis J,Luukkainen R, Mofti A, Murphy E, Nakajima A, Oyoo O, Pandya SC, Pohl C, Predeteanu D,Rexhepi M, Rexhepi S, Sharma B, Shono E, Sibilia J, Sierakowski S, Skopouli FN,Stropuviene S, Toloza S, Valter I, Woolf A, H Yamanaka, and the QUEST-RA Study Group.Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32countries in the QUEST-RA study. Arthritis Res Ther 2010; 12(2):R42.http://goo.gl/mrmeF.

[5] Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F, Skakic V, Badsha H, Oeets T,Baranauskaite A, Geher P, Ujfalussy I, Skopouli FN, Mavrommati M, Alten R, Pohl C, Sibilia J,Stancati A, Salaffi F, Romanowski W, Zarowny-Wierzbinska D, Henrohn D, Bresnihan B,Minnock P, Surland Knudsen L, Jacobs JWG, Calvo-Alen J, Lazovskis J, da Rocha CastelarPinheiro G, Karateev D, Andersone D, Rexhepi S, Yazici Y, Pincus T, and QUEST-RA Group.Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics,and treatments in the QUEST-RA Study. Arthritis Res Ther 2009; 11:R7.http://goo.gl/Beh0o.

[4] Sokka T, Hetland ML, Mäkinen H, Kautiainen H, Hørslev-Petersen K, Luukkainen RK,Combe B, Badsha H, Drosos AA, Devlin J, Ferraccioli G, Morelli A, Hoekstra M, Majdan M,Sadkiewicz S, Belmonte M, Holmqvist AC, Choy E, Burmester GR, Tunc R, Dimic A,Nedovic J, Stankovic A, Bergman M, Toloza S, and Pincus T for the Questionnaires inStandard Monitoring of Patients With Rheumatoid Arthritis Group. Remission andrheumatoid arthritis: data on patients receiving usual care in twenty-four countries. ArthritisRheum 2008; 58(9):2642–2651. http://goo.gl/B6tni.

[3] Naranjo A, Sokka T, Descalzo MA, J Calvo-Alén, Hørslev-Petersen K, Luukkainen RK,Combe B, Burmester GR, Devlin J, Ferraccioli G, Morelli A, Hoekstra M, Majdan M,Sadkiewicz S, Belmonte M, Holmqvist AC, Choy E, Tunc R, Dimic A, Bergman M, Toloza S,Pincus T, and QUEST-RA Group. Cardiovascular disease in patients with rheumatoidarthritis: results from the QUEST-RA study. Arthritis Res Ther 2008; 10(2):R30.http://goo.gl/fZwDR.

Last Updated: July 16, 2014 13 of 26

[2] Sokka T, Häkkinen A, Kautiainen H, Maillefert JF, Toloza S, Mørk Hansen T, Calvo-Alen J,Oding R, Liveborn M, Huisman M, Alten R, Pohl C, Cutolo M, Immonen K, Woolf A, Murphy E,Sheehy C, Quirke E, Celik S, Yazici Y, Tlustochowicz W, Kapolka D, Skakic V, Rojkovich B,Müller R, Stropuviene S, Andersone D, Drosos AA, Lazovskis J, Pincus T, and QUEST-RAGroup. Physical inactivity in patients with rheumatoid arthritis: data from twenty-onecountries in a cross-sectional, international study.. Arthritis Rheum 2008; 59(1):42–50.http://goo.gl/z0J6O.

[1] Sokka T, Kautiainen H, Toloza S, Mäkinen H, Verstappen SM, Lund Hetland M, Naranjo A,Baecklund E, Herborn G, Rau R, Cazzato M, Gossec L, Skakic V, Gogus F, Sierakowski S,Bresnihan B, Taylor P, McClinton C, Pincus T, and QUEST-RA Group. QUEST-RA:quantitative clinical assessment of patients with rheumatoid arthritis seen in standardrheumatology care in 15 countries. Ann Rheum Dis 2007; 66(11):1491–1496.http://goo.gl/vtGxk.

OTHER

PUBLICATIONS [11] Swearingen CJ, Melguizo castro MS, and Bursac Z. Inflated Beta Regression: Zero, one,and everything in between. SASR© Global Forum Proceedings 2012; 325:1–11.http://goo.gl/NtrTp.

[10] Howard RG, Pillinger MH, Gyftopoulos S, Theile R, Swearingen CJ, and Samuels J.Response to letter to the editor by Filippou MD, et al. on the article by Howard RG, PillingerMH, Gyftopoulos S et al. Reproducibility of Musculoskeletal Ultrasound for DeterminingMonosodium Urate Deposition: Concordance Between Readers. Arthritis Care Res. 2011Oct;63(10):1456162. doi: 10.1002/acr.20527. Arthritis Care Res 2012; 64(5):795–796.http://goo.gl/Elwcf.

[9] Swearingen CJ, Melguizo castro MS, and Bursac Z. Modeling percentage outcomes: The%Beta_Regression macro. SASR© Global Forum Proceedings 2011; Paper 335:1–12.http://goo.gl/n2M0V.

[8] Melguizo castro MS, Stalnaker JR, and Swearingen CJ. Using Microsoft Access 2007description of field names in tables as variable labels in SAS datasets. SASR© Global ForumProceedings 2011; Paper 236:1–5. http://goo.gl/omVrH.

[7] Gossett JM, Aitken ME, Miller BK, and Swearingen CJ. Contrast statements for binaryresponses: Comparing and constrasting with PROC GLIMMIX. SASR© Global ForumProceedings 2011; Paper 216:1–10. http://goo.gl/zGzMt.

[6] Pincus T, Yazici Y, and Swearingen CJ. Quality control of a medical history: improvingaccuracy with patient participation, supported by a four-page version of the multidimensionalhealth assessment questionnaire (MDHAQ). Rheum Dis Clin North Am 2009;35(4):851–860. http://goo.gl/jWbSi.

[5] Pincus T, Mandelin AM, and Swearingen CJ. Flowsheets that include MDHAQ physicalfunction, pain, global, and RAPID3 scores, laboratory tests, and medications to monitorpatients with all rheumatic diseases: an electronic database for an electronic medicalrecord. Rheum Dis Clin North Am 2009; 35(4):829–842. http://goo.gl/GSgRJ.

[4] Pincus T, Askanase AD, and Swearingen CJ. A multi-dimensional health assessmentquestionnaire (MDHAQ) and routine assessment of patient index data (RAPID3) scores areinformative in patients with all rheumatic diseases. Rheum Dis Clin North Am 2009;35(4):819–827. http://goo.gl/SMshB.

[3] Pincus T and Swearingen CJ. The HAQ compared with the MDHAQ: "keep it simple, stupid"(KISS), with feasibility and clinical value as primary criteria for patient questionnaires in usualclinical care. Rheum Dis Clin North Am 2009; 35(4):787–798. http://goo.gl/FSIdF.

[2] Swearingen CJ (Editor). Forty Years of Analytical Contributions to Biomedical Research,1968 - 2008. (Department of Biostatistics, Bioinformatics and Epidemiology, College ofMedicine, Medical University of South Carolina, Charleston, SC, 2008).http://goo.gl/VGAw0.

Last Updated: July 16, 2014 14 of 26

[1] Pincus T, Yazici Y, Bergman M, Swearingen C, and Harrington T. A proposed approach torecognise "near-remission" quantitatively without formal joint counts or laboratory tests: apatient self-report questionnaire routine assessment of patient index data (RAPID) score asa guide to a "continuous quality improvement" strategy. Clin Exp Rheumatol 2006; 24(6Suppl 43):S–60–5. http://goo.gl/akquh.

ORAL

PRESENTATIONS [20] Jeffs D, Dorman D, Brown S, Files A, Graves T, Kirk E, Meredith-Neve S, Sanders J, White B,and Swearingen C. Effect of virtual reality on adolescent pain during burn wound care. 45th

Annual Meeting of the American Burn Association 2013; p. #23. http://goo.gl/WBwFY.

[19] Bozeman AP, Dassinger MS, Jackson RJ, Maxson RT, Kelley KR, Mathews DL, Li J,Swearingen CJ, and Smith SD. Persistent Gastrocutaneous Fistula: Factors affecting needfor closure. American Academy of Pediatrics National Conference & Exhibition 2012;H2016:#18074. http://goo.gl/E3Gkz.

[18] Byrnes JW, Swearingen CJ, Parthak P, Fiser RT, and Dyamenahalli U. Effect of Antithrombinsupplementation in pediatric cardiac Extracorporeal Membrane Oxygenation. AmericanAcademy of Pediatrics National Conference & Exhibition 2012; H2022:#17065.http://goo.gl/j0KBr.

[17] Canon SJ, Recicar J, Swearingen CJ, Maxson RT, and Linam LE. The utility of initial andfollow-up ultrasound reevaluation for blunt renal trauma in children and adolescents.American Academy of Pediatrics National Conference & Exhibition 2012; H1016:#18018.http://goo.gl/H2W2v.

[16] Redwine K, Brown W, Binz T, and Swearingen C. Effect of environmental tobacco exposureon blood pressure in children. Pediatric Academic Societies 2012; E-PAS2012:1450.6.http://goo.gl/D5LyI.

[15] Swearingen CJ, Melguizo castro MS, and Bursac Z. Inflated beta regression: Zero, one, andeverything in between. SASR© Global Forum. 2012; Invited.

[14] Swearingen CJ. When data act weird: Challenges in modeling Non-Normal data. Universityof Arkansas – Little Rock Biosciences Lecture. 2011; Invited.

[13] Canon S, Purifoy J, Basham K, and Swearingen C. Alternative approaches to expandingpediatric urology services and productivity. American Academy of Pediatrics NationalConference 2011; #14226. http://goo.gl/xXE6u.

[12] Zakaria D, Frazier EA, Imamura M, Gossett J, Pye S, Knecht KR, Morrow WR, andSwearingen C. Improved survival while waiting in pediatric patients listed for cardiactransplantation. American Academy of Pediatrics National Conference 2011; #14930.http://goo.gl/fZVJF.

[11] Garcia X, Sachdeva R, Bhutta A, Prodhan P, Swearingen C, and Kane J. A novel paradigmfor providing improved care to chronic patients in Cardiac Intensive Care Unit. AmericanAcademy of Pediatrics National Conference 2011; #15251. http://goo.gl/Tg8f7.

[10] Melguizo castro MS8, Stalnaker JR, and Swearingen CJ. VBA Microsoft Access 2007macros to import formats and labels to SASR©. Western Users of SAS Software Conference2011.

[9] Swearingen CJ. Discussion on “Perspectives on Reproducible Research: Moving fromBuzzword to Doctrine”. Joint Statistical Meetings. 2011.

[8] Ince DC, Swearingen C, and Yazici Y. Pain in children 9-15 years old using gameconsoles/handhelds and mobile phones: Implications for policy makers. European LeagueAgainst Rheumatism 2011.

8Received Junior Professional Award for the 2011 WUSS Conference

Last Updated: July 16, 2014 15 of 26

[7] Filopoulus M, Kimura M., Kishimoto M, Kobayashi T, Matsui K, Ohara Y, Oshikawa H,Swearingen C, Tokuda Y, Utsunomiya M, Yazici Y, and Yoshida K. The difference ofconcordance rates between two major criteria of Behcet’s syndrome in the United Statesand Japan. European League Against Rheumatism 2011.

[6] Swearingen CJ, Melguizo castro MS, and Bursac Z. Modeling percentage outcomes: The%Beta_Regression macro. SASR© Global Forum 2011; 335.

[5] Brown CM, Boateng BA, Lloyd C, and Swearingen CJ. Improving resident self-efficacy inpediatric palliative care using clinical simulation. American Academy of Hospice andPalliative Medicine & Hospice and Palliative Nurses Association 2011.

[4] Canon S, Purifoy J, Heulitt G, Hogan WR, Swearingen C, Williams MA, Alpert SA, andD. Young. Pediatric urology survey of electronic medical records: Usage and perspectives.American Academy of Pediatrics National Conference & Exhibition. 2010; #11828.

[3] Swearingen CJ and Nick TG. The bureaucracy of translational research: Regulatorychallenges facing the consulting statistician. Joint Statistical Meetings. Given as part of acontributed session “Consulting for Translational Research: Emerging Issues andRecommendations” 2010.

[2] Swearingen CJ, Bandyopadhyay D, Woolson RF, and Tilley BC. Performance of betaregression in detecting independent group differences. Eastern North American Region(ENAR) of the International Biometric Society. 2010.

[1] Swearingen CJ. Generalized linear models using the beta distribution. Central ArkansasStatistical Association. Invited. 2009.

POSTER

PRESENTATIONS [25] Swearingen CJ and Kaiser JR. Propensity score matching to estimate effect of treatingtransient newborn hypoglycemia. Pediatric Academic Societies 2013; E-PAS2013:3836.604.http://goo.gl/bFjVE.

[24] Lohmann P, Swearingen CJ, and Kaiser JR. Partial exchange transfusions in newborns: Is itjust the hematocrit that is being lowered? Pediatric Academic Societies 2013;E-PAS2013:3836.558. http://goo.gl/sZN6Q.

[23] Reeves DM, Kaiser JR, Gossett JM, Swearingen CJ, Malik S, and Sachdeva R. Antegradepulmonary artery diastolic velocity is associated with spontaneous closure of the ductusarteriosus in extremely low birth weight infants. Pediatric Academic Societies 2013;E-PAS2013:2923.418. http://goo.gl/dgy2h.

[22] Mulkey SB, Swearingen CJ, Melguizo MS, Reeves RN, Rowell JA, Kaiser JR, and Bhutta AT.Predictors of academic achievement in children with a history of congenital heart disease(CHD) surgery in infancy. Pediatric Academic Societies 2013; E-PAS2013:1532.433.http://goo.gl/qX329.

[21] Redwine K, Binz T, Brown W, and Swearingen CJ. Blood pressure (BP) variability in childrenwith elevated BP. Pediatric Academic Societies 2013; E-PAS2013:1525.360.http://goo.gl/ZfoHH.

[20] Binz T, Brown W, Swearingen CJ, and Redwine K. Determinants of hypertension (HTN) inchildren. Pediatric Academic Societies 2013; E-PAS2013:1525.350.http://goo.gl/Ydcwr.

[19] Boateng BA, Swearingen CJ, Bass LD, Farrar HC, and Blaszak RT. A self assessment rubricto facilitate the measurement of pediatric milestones and development of ILPs: Lessonslearned. ACGME Annual Education Conference 2013; # 14.

[18] Irby KO, Swearingen CJ, Byrnes JW, Bryant J, Fiser RT, and Prodhan P. TherapeuticHeparin Anti-Factor Xa concentrations are associated with freedom from circuit change inchildren supported with ECMO. 42nd Critical Care Congress – Society of Critical CareMedicine 2013; # 280.

Last Updated: July 16, 2014 16 of 26

[17] Garlick J, Linam W, Maples H, Furlong-Dillard J, Swearingen CJ, Brown A, and Green J. Theuse of antimicrobials in respiratory disease in a PICU. 42nd Critical Care Congress –Society of Critical Care Medicine 2013; # 723.

[16] Reeves DM, Kaiser JR, Gossett JM, Swearingen CJ, Malik S, and Sachdeva R. Antegradepulmonary artery diastolic velocity is associated with spontaneous closure of the DuctusArteriosus in extremely low birth weight infants. American Academy of Pediatrics NationalConference & Exhibition 2012; # 17838. http://goo.gl/npGzg.

[15] Kaiser JK, Mehl JK, Bornhorst JA, and Swearingen CJ. Pattern of initial newborn glucoseconcentrations (before treatment or feeding) by gestational age. Pediatric AcademicSocieties 2012; E-PAS2012:1536.643. http://goo.gl/bcXpT.

[14] Kaiser JK, Mehl JK, Bornhorst JA, and Swearingen CJ. Treatment of newborn hypoglycemiaimproves student achievement test scores. Pediatric Academic Societies 2012;E-PAS2012:2916.229. http://goo.gl/qYz9c.

[13] Linam WM, Gilliam CH, Joneycutt MD, Wisdom CM, Swearingen CJ, and Romero JR.Parental perceptions about mandatory influenza immunization of pediatric healthcareworkers. Pediatric Academic Societies 2012; E-PAS2012:2915.207.http://goo.gl/Femsa.

[12] Mulkey SB, Yap VL, Swearingen CJ, Kaiser JR, Riggins MS, and Schaefer GB. Follow-upvolumetric brain measurements associated with adverse neurodevelopmental outcomes innewborn hypoxic ischemic encephalopathy (HIE). Pediatric Academic Societies 2012;E-PAS2012:4505.54. http://goo.gl/2hT9r.

[11] Swearingen CJ and Kaiser JK. Using nomograms to visualize association of newbornhypoglycemia and student achievement-test proficiency. Pediatric Academic Societies 2012;E-PAS2012:2916.242. http://goo.gl/ES3qD.

[10] Jeffs D, Dorman D, Brown S, Files A, Goforth E, Graves T, Killebrew P, Kirk E,Meredith-Neve S, Sanders J, White B, Braden E, Hill T, and Swearingen C. Comparison ofvirtual reality and passive distraction on burn wound care pain in adolescents. 22nd AnnualConference of the Society of Pediatric Nurses 2012.

[9] Jeffs D, Dorman D, Brown S, Files A, Goforth E, Graves T, Killebrew P, Kirk E,Meredith-Neve S, Sanders J, White B, Braden E, Hill T, and Swearingen C. Comparison ofvirtual reality and passive distraction on burn wound care pain in adolescents. 26th AnnualConference, Southern Nursing Research Society 2012.

[8] Peeples SE, McCracken A, Swearingen C, and Miquel-Verges F. Neonatal and obstetric careand counseling at the threshold of viability. American Academy of Pediatrics NationalConference 2011. http://goo.gl/B6XzZ.

[7] Melguizo castro MS, Stalnaker JR, and Swearingen CJ. Using Microsoft Access 2007description of field names in tables as variable labels in SAS datasets. SASR© Global ForumProceedings 2011; #236.

[6] Gossett JM, Aitken ME, Miller BK, and Swearingen CJ. Contrast statements for binaryresponses: Comparing and constrasting with PROC GLIMMIX. SASR© Global ForumProceedings 2011; #216.

[5] Clemmons JC, Worley KB, and Swearingen CJ. A comparison of clinical recommendationsand judicial decisions regarding adolescent sex offender registration. Association forBehavioral and Cognitive Therapies Annual Convention. 2010.

[4] Brown CM, Boateng BA, Swearingen CJ, and Lloyd EC. Improving resident self-efficacy inpediatric palliative care using clinical simulation. International Palliative Care Network PosterExhibition 2010; #37. http://goo.gl/osMbW.

[3] Byrnes J, McKamie W, Swearingen C, Bhutta A, Prodhan P, Imamura M, Jaquiss RDB, andFiser R. Hemolysis is increased in cardiac extracorporeal life support with roller-headpumps as compared to centrifugal pumps. American Academy of Pediatrics NationalConference. 2010; #11559.

Last Updated: July 16, 2014 17 of 26

[2] Swearingen CJ and Bandyopadhyay D. Further development of semiparametric methods inbayesian beta regression. Eastern North American Region (ENAR) of the InternationalBiometric Society. 2009.

[1] Swearingen CJ. Using concordance correlation and multiple imputation to combine twodifferent assessments of the same construct. Eastern North American Region (ENAR) ofthe International Biometric Society. 2008.

PUBLISHED

ABSTRACTS [97] Jeffs D, Dorman D, Brown S, Files A, Graves T, Kirk E, Meredith-Neve S, Sanders J, White B,and Swearingen C. Effect of virtual reality on adolescent pain during burn wound care. JBurn Care Res 2013; 34(Suppl 1):S75. http://goo.gl/ITDdC.

[96] Kerr GS, Yazici Y, Swearingen CJ, Espinoza LR, Treadwell EL, Sherrer YRS,Mosley-Williams AD, Ince A, Nair RG, Ford TL, Huang J, and Nunziato CA. Patient versusphysician global assessments in ethnic patients with rheumatoid arthritis. Arthritis Rheum2012; 64(10 Supp):2102.

[95] Frem J, Chu C, Swearingen CJ, Gibbons TE, and Fuchs GJ. The Modified WHO Protocol inthe management of severe acute malnutrition in developed countries: A pilot study. J PediatrGastroenterol Nutr 2012; 55(Suppl 1):#273.

[94] Redwine KM, Brown W, Binz T, and Swearingen C. Effect of cardiovascular disease (CVD)risk factors on blood pressure (BP) in children. Clin Transl Sci 2012; 5(2):147.

[93] Howard RNG, Samuels J, Gyftopoulos S, Krasnokutsky S, Leung J, Swearingen CJ, andPillinger MH. Presence of Gout is associated with increased Osteoarthritis prevalence andseverity. Arthritis Rheum 2011; 63(Supp):1083.

[92] Kerr GS, Sherrer YRS, Nair RG, Treadwell EL, Mosley-Williams AD, Mubashir AM,Espinoza ER, Huang J, Swearingen CJ, and Yazici Y. Ethnic Minority Rheumatoid ArthritisConsortium: A clinical registry of minority patients with Rheumatoid Arthritis. ArthritisRheum 2011; 63(Supp):2110.

[91] Ohara Y, Kishimoto M, Kobayashi T, Swearingen CJ, Filopoulous MT, Tokuda Y, Oshikawa H,Yoshida K, Utsunomiya M, Kimura M, Okada M, Matsui K, and Yazici Y. Difference ofmanifestations and treatment among Behcet’s Syndrome patients in the United States andJapan. Arthritis Rheum 2011; 63(Supp):2396.

[90] Yazici Y, Filopoulos MT, and Swearingen CJ. Comparative effectiveness and time toresponse among Abatacept, Adalimumab, Etanercept and Infliximab for the treatment ofRheumatoid Arthritis in a real world routine care registry. Arthritis Rheum 2011;63(Supp):2233.

[89] Yazici Y, Swearingen CJ, Nadkarni A, and Rosenblatt L. Comparative efficacy and tolerabilityof biologic therapies in early Rheumatoid Arthritis utilizing a Bayesian approach. ArthritisRheum 2011; 63(Supp):1240.

[88] Yazici Y, Swearingen CJ, Sherrer YRS, Nair RG, Treadwell EL, Mosley-Williams AD,Espinoza ER, Mubashir AM, Huang J, and Kerr GS. Disease activity levels and treatmentpatterns amongst Ethnic Minority Rheumatoid Arthritis Consortium patients. Arthritis Rheum2011; 63(Supp):2126.

[87] Yazici Y, Filopoulous MT, and Swearingen CJ. RAPID3 remission vs new ACR RheumatoidArthritis Remission Criteria: RAPID3 has similar utility and may be used in everyday clinicalcare. Arthritis Rheum 2011; 63(Supp):2461.

[86] Ince DC, Swearingen C, and Yazici Y. Pain in children 9-15 years old using gameconsoles/handhelds and mobile phones: Implications for policy makers. Ann Rheum Dis2011; 70(Suppl3):67.

Last Updated: July 16, 2014 18 of 26

[85] Kobayashi T, Kishimoto M, Swearingen C, Filopoulus M, Ohara Y, Tokuda Y, Oshikawa H,Yoshida K, Utsunomiya M, Kimura M., Matsui K, and Yazici Y. The difference of concordancerates between two major criteria of Behcet’s syndrome in the United States and Japan. AnnRheum Dis 2011; 70(Suppl3):160.

[84] Brown CM, Boateng BA, Lloyd EC, and Swearingen CJ. Improving resident self-efficacy inpediatric palliative care using clinical simulation. J Pain Symptom Manage 2011;41:231–232.

[83] Uppu SC, Dyamenahalli U, Sachdeva R, Jaquiss RD, Morrow WR, Gossett JM,Swearingen CJ, and Vyas HV. Wider conal septal angle in neonates with Tetralogy of Fallotis associated with rapid progression of right ventricular outflow tract obstruction. Circulation2010; 122:A21484. http://goo.gl/GFn3l.

[82] Howard RG, Pillinger MH, Gyftopoulos S, Theile R, Swearingen C, and Samuels J.Concordance between ultrasound readers determining the presence of monosodium uratecrystal deposition in the knee and toe joints. Arthritis Rheum 2010; 62(9 Supp):1616.

[81] Diaz MV, Shadakshari A, McCracken A, Swearingen C, Ricciardi D, and Yazici Y. In SystemicLupus Erythematosus (SLE) patients, patient reported outcomes and physician assessmentof disease activity are poorly correlated: Implications for outcome measures in SLE. ArthritisRheum 2010; 62(9 Supp):1863.

[80] Nowatzky J, Filopoulos MT, Swearingen C, and Yazici Y. Eye involvement in BehcetŠsSyndrome patients in a North American cohort. Arthritis Rheum 2010; 62(9 Supp):1298.

[79] Yazici Y, Filopoulos MT, Schimmel E, McCracken A, and Swearingen C. Clinicalcharacteristics, treatment and ethnic/racial differences in the manifestations of 518BehcetŠs Syndrome patients in the United States. Arthritis Rheum 2010; 62(9 Supp):1284.

[78] Yazici Y and Swearingen C. Etanercept, Adalimumab and Abatacept combination withMethotrexate have lower odds ratios of discontinuations due to adverse events and seriousinfections compared to Infliximab and Methotrexate combination: An analysis of RCT data.Ann Rheum Dis 2010; 69(Supp 3):509.

[77] Labitigan M, Sharaf PH, Swearingen C, and Yazici Y. Rheumatoid arthritis patients whoparticipated in randomized clinical trials in 1980s versus 2000s: Clinical implications ofsimilarities and differences. Ann Rheum Dis 2010; 69(Suppl 3):508.

[76] Pincus T, Swearingen CJ, Bergman M, Colglazier CL, Kaell A, Kunath A, Siegel E, andYazici Y. Joint damage estimates by rheumatologists in patients with rheumatoid arthritis(RA) are correlated similarly with swollen joint count, ESR and DAS28 as with patientself-report scores for function, pain and global estimate. Ann Rheum Dis 2010; 69(Suppl3):718.

[75] Masatlioglu S, Goktay F, Swearingen C, and Yazici Y. Comparison of RAPID3, DAS28,BASDAI And PASI in Psoriatic Arthritis patients in routine care: RAPID3, composed ofpatient measures only, is strongly correlated with DAS28, BASDAI and not with PASI. AnnRheum Dis 2010; 69(Suppl 3):700.

[74] Kushnir M, Ashurova A, Shriky R, Swearingen C, and Yazici Y. Infliximab, Abatacept AndRituximab use in the treatment of rheumatoid arthritis in the real world: View from theinfusion unit. Ann Rheum Dis 2010; 69(Suppl 3):675.

[73] Pincus T and Swearingen CJ. Patient questionnaire scores for physical function and pain aremore likely than erythrocyte sedimentation rate (ESR) to document a quantitativeabnormality in new patients with rheumatoid arthritis (RA). Ann Rheum Dis 2010; 69(Suppl3):674.

[72] Pincus T and Swearingen CJ. RAPID3 and component measures are as likely as a DAS28and component measures to identify patients with rheumatoid arthritis (RA) who havemoderate/high disease activity versus low activity at presentation. Arthritis Rheum 2009;60(10 Supp):1920.

Last Updated: July 16, 2014 19 of 26

[71] Pincus T and Swearingen CJ. Documenting adequate versus incomplete responses tomethotrexate (MTX) at initiation of biologic agents in routine clinical care, according to ESR,RAPID3, and component patient-reported scores for physical function, pain and globalestimate. Arthritis Rheum 2009; 60(10 Supp):1627.

[70] Ince DC, Swearingen CJ, and Yazici Y. Wrist pain in 7-12 year olds playing with gameconsoles/handhelds: Younger children have more pain, independent from time spentplaying. Arthritis Rheum 2009; 60(10 Supp):1234.

[69] Yazici Y, Schimmel E, and Swearingen CJ. Behcet’s Syndrome (BS) in the US: Clinicalcharacteristics, treatment and ethnic/racial differences in manifestations in 347 patients withBS. Arthritis Rheum 2009; 60(10 Supp):649.

[68] Kurtulus D, Bahadir C, Swearingen CJ, and Yazici Y. Comparison of RAPID3, BASDAI andBASFI in Ankylosing Spondylitis patients in routine care: RAPID3, composed of patientmeasures only, is strongly correlated with BASDAI and BASFI. Arthritis Rheum 2009; 60(10Supp):510.

[67] Pincus T and Swearingen CJ. DAS28 and RAPID3 based on patient questionnaire scoresare more likely than ESR to indicate a quantitative abnormality at initiation of methotrexatetherapy, to monitor improvement in status in 201 patients with rheumatoid arthritis. ArthritisRheum 2009; 60(10 Supp):432.

[66] Pincus T and Swearingen CJ. Decline of mean initial prednisone dose from 10.3 mg/day in1980-1985 to 3.6 mg/day in 2000-2004 with similar efficacy over 12 subsequent months.Arthritis Rheum 2009; 60(10 Supp):425.

[65] Pincus T and Swearingen CJ. Erythrocyte sedimentation rate (ESR) is the least likely ofCore Data Set measures to identify an "abnormal state" in new patients with RA to monitortherapeutic responses, according to 3 definitions of “abnormal state”. Arthritis Rheum 2009;60(10 Supp):318.

[64] Kobayashi T, Kishimoto M, Tokuda Y, Schimmel EK, Swearingen C, Yoshida K,Utsunomiya M, Yamamoto M, and Yazici Y. Disease manifestations and treatmentdifferences among Behcet’s Syndrome patients in the United States and Japan. Ann RheumDis 2009; 68(Supp III):609.

[63] Swearingen C and Yazici Y. A reappraisal of the ACR classification criteria for rheumatoidarthritis: Do we need new criteria for early RA patients? Ann Rheum Dis 2009; 68(SuppIII):572.

[62] Yazici Y, Schimmel EK, and Swearingen C. Hispanic early RA patients report worse diseasemeasures at baseline than Caucasian or African American patients however all racial/ethnicgroups respond at similar levels to DMARD treatment at 2 years. Ann Rheum Dis 2009;68(Supp III):735.

[61] Yazici Y, Kilfoy SM, Rognan TN, Ingber E, Swearingen C, Shriky R, and Ince A. Infusiblebiologic use in an academic and a private setting: Different agents are preferred with samelow infusion reaction rates with very few discontinuations. Ann Rheum Dis 2009; 68(SuppIII):741.

[60] Khan NA, Spencer HJ, Swearingen C, Tammaru M, Géher P, da Mota LMH, da Silveira I,Hansen T, Maillefert J, Alten R, Pohl C, Skopouli FN, Mavrommati M, Sharma B, Minnock P,Murphy E, Cazzato M, Salaffi F, Shono E, Huisman M, Kapolka D, Sadkiewicz S, Dimic A,Nedovic J, Naranjo A, Taylor P, McClinton C, and Sokka T. Determinants of discordance inpatients and physicians assessment of rheumatoid arthritis disease activity. Ann Rheum Dis2009; 68(Supp III):563.

[59] Pincus T and Swearingen C. Prednisone in initial doses less than 5 mg/day is as efficaciousas larger doses in patients with rheumatoid arthritis (RA). Ann Rheum Dis 2009; 68(SuppIII):593.

Last Updated: July 16, 2014 20 of 26

[58] Pincus T and Swearingen C. Documenting incomplete response to methotrexate (MTX) instandard clinical care at initiation of therapy with biologic agents, according to erythrocytesedimentation rate (ESR) and patient questionnaire scores for physical function and pain.Ann Rheum Dis 2009; 68(Supp III):592.

[57] Pincus T and Swearingen CJ. Erythrocyte sedimentation rate (ESR) is less likely thanpatient questionnaire scores for physical function and pain to indicate a quantitativeabnormality in 413 new patients with rheumatoid arthritis (RA), to assess status and monitorclinical improvement. Ann Rheum Dis 2009; 68(Supp III):737.

[56] Pincus T and Swearingen CJ. Erythrocyte sedimentation rate (ESR) is less likely to indicatea quantitative abnormality than patient questionnaire scores for physical function and pain atinitiation of methotrexate (MTX) therapy, to monitor improvement in status in 201 patientswith rheumatoid arthritis (RA). Ann Rheum Dis 2009; 68(Supp III):551.

[55] Pincus T, Yazici Y, Bergman M, and Swearingen CJ. Physician/assessor global estimate ofpatient status: Analysis of intra-observer and inter-observer agreement. Ann Rheum Dis2009; 68(Supp III):98.

[54] Pincus T, Swearingen C, Bergman M, Colglazier CL, Kaell A, Kunath A, Siegel E, andYazici Y. Joint damage estimates by rheumatologists in 250 patients with rheumatoidarthritis (RA) are correlated at higher levels with swollen joint count, erythryocytesedimentation rate (ESR) and Disease Activity Score (DAS28), than with patient self-reportscores. Ann Rheum Dis 2009; 68(Supp III):767.

[53] Pincus T, Bergman M, Yazici Y, and Swearingen C. DAS28-ESR (Disease Activity ScoreWith Erythrocyte Sedimentation Rate) is correlated at similar levels with RAPID3 (RoutineAssessment Of Patient Index Data), an index of only patient self-report measures, as withC-Reactive Protein (CRP) in patients with rheumatoid arthritis (RA). Ann Rheum Dis 2009;68(Supp III):538.

[52] Fischer A, Swearingen C, du Bois RM, Swigris JJ, Yorke J, Ries AL, Kaplan RM, andPincus T. Multi-Dimensional Health Assessment Questionnaire self-report scores correlatewith self-report of dyspnea and pulmonary function tests in patients with rheumatic diseasesand pulmonary comorbidity. Ann Rheum Dis 2009; 68(Supp III):342.

[51] Forbess C, Swearingen C, and Yazici Y. Behcet’s Syndrome Activity Score (BSAS): A newdisease activity assessment tool, composed of patient-derived measures only, is stronglycorrelated with the Behcet’s Disease Current Activity Form (BDCAF). Arthritis Rheum 2008;58(11 Supp):1875.

[50] Yazici Y, Swearingen C, and Schimmel E. Hispanic early RA patients report worse diseasemeasures at baseline than Caucasian or African American patients however all racial/ethnicgroups respond at similar levels to DMARD treatment at 2 years. Arthritis Rheum 2008;58(11 Supp):1385.

[49] Pincus T and Swearingen C. Documenting quality of rheumatology care with a quantitativeRAPID3 (Routine Assessment of Patient Index Data) score in every patient with anyrheumatic diagnosis at every visit using a 1-page Multidimensional Health AssessmentQuestionnaire (MDHAQ). Arthritis Rheum 2008; 58(11 Supp):1583.

[48] Colglazier CL, Swearingen C, Kaell A, Kunath A, Siegel E, Bergman M, Yazici Y, andPincus T. Time to score indices to assess clinical status in RA: Disease Activity Score(DAS28), Clinical Disease Activity Index (CDAI), Easy Rheumatoid Arthritis Measure(ERAM) and Routine Assessment of Patient Index Data (RAPID3) in usual clinical care.Arthritis Rheum 2008; 58(11 Supp):1582.

[47] Pincus T, Swearingen C, Bergman M, Colglazier CL, Kaell A, Kunath A, Siegel E, andYazici Y. Further evidence of significant associations of Routine Assessment of Patient IndexData 3 (RAPID3) with Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index(CDAI) in patients with rheumatoid arthritis (RA). Arthritis Rheum 2008; 58(11 Supp):1384.

Last Updated: July 16, 2014 21 of 26

[46] Pincus T and Swearingen C. First prednisone dose in 329 patients with rheumatoid arthritis(RA) in one rheumatology practice: Reduction from 8.6 to 4.1 mg/day between 1982 and2006. Ann Rheum Dis 2008; 67(Suppl II):612.

[45] Pincus T and Swearingen C. Efficacy of prednisone in doses of less than 5 mg/day in regularclinical care of 123 patients with rheumatoid arthritis (RA) from 1986-2006. Ann Rheum Dis2008; 67(Suppl II):612.

[44] Pincus T and Swearingen C. Documenting quality of rheumatology care with a quantitativeRAPID3 (Routine Assessment Of Patient Index Data) score in every patient at every visitusing a 1-page Multidimensional Health Assessment Questionnaire (MDHAQ). Ann RheumDis 2008; 67(Suppl II):575.

[43] Forbess C, Swearingen C, and Yazici Y. Behcet’s Syndrome Activity Score (BSAS): A newdisease activity assessment tool, composed of patient-derived measures only, is stronglycorrelated with the Behcet’s Disease Current Activity Form (BDCAF). Ann Rheum Dis 2008;67(Suppl II):360.

[42] Pincus T, Yazici Y, Bergman MJ, Roth J, Sokka T, and Swearingen C. Simplified formats ofvisual analog scales (VAS) for use in usual rheumatology clinical care: Agreement between10 cm horizontal line and 21 numbered circles which require half the time to score. AnnRheum Dis 2008; 67(Supp II):310.

[41] Pincus T and Swearingen C. A randomized controlled withdrawal clinical trial documents theefficacy of 1-4 mg per day of prednisone in patients with rheumatoid arthritis. Ann RheumDis 2008; 67(Suppl II):203.

[40] Pincus T, Krishnaswami S, and Swearingen C. Prediction of mortality over 5-20 years in 210patients with rheumatoid arthritis from 1985-2005 according to a Multidimensional HealthAssessment Questionnaire (MDHAQ), swollen joint counts with 28, 42 or 66 joints, age andgender. Arthritis Rheum 2007; 56:S406.

[39] Pincus T and Swearingen C. Maintenance of improvement seen at 6 months over 5 years inpatients with rheumatoid arthritis treated in standard care according to a policy of "tightcontrol" using a Multidimensional Health Assessment Questionnaire (MDHAQ) and RoutineAssessment of Patient Index Data (RAPID3) scores at each visit. Arthritis Rheum 2007;56:S111.

[38] Pincus T and Swearingen C. Efficacy of low dose prednisone (1-4 mg/day) in patients withrheumatoid arthritis: A randomized controlled placebo controlled double-blind withdrawaltrial. Arthritis Rheum 2007; 56:S169.

[37] Pincus T, Yazici Y, Bergman M, and Swearingen C. Physician estimate of global status:Analysis of intra-observer and inter-observer reliability. Ann Rheum Dis 2007; 66(SuppII):632.

[36] Pincus T and Swearingen C. An index of only patient Multidimensional Health AssessmentQuestionnaire (MDHAQ) data, Routine Assessment Of Patient Index Data (RAPID), at eachvisit in standard care, to maintain “tight control” of rheumatoid arthritis over 5 years withoutformal joint count. Ann Rheum Dis 2007; 66(Supp II):446.

[35] Pincus T, Yazici Y, Bergman M, and Swearingen C. Comparisons of a self-reportRheumatoid Arthritis Disease Activity Index (RADAI) joint count to American College OfRheumatology (ACR) Core Data Set measures for rheumatoid arthritis (RA). Ann RheumDis 2007; 66(Supp II):335.

[34] Pincus T and Swearingen C. Maintenance of improvement over 5 years in patients withrheumatoid arthritis treated in standard care after 1996 according to a policy of tight control,documented according to a Multidimensional Health Assessment Questionnaire (MDHAQ)at each visit. Ann Rheum Dis 2007; 66(Supp II):335.

Last Updated: July 16, 2014 22 of 26

[33] Pincus T, Yazici Y, Bergman M, and Swearingen C. An index without formal joint counts,Routine Assessment Of Patient Index Data (RAPID3), to help guide tight control of RA instandard care: Most patients who meet DAS or CDAI remission or high activity criteria meetidentical preliminary RAPID criteria. Ann Rheum Dis 2007; 66(Supp II):271.

[32] Pincus T, Bergman M, Yazici Y, and Swearingen C. A composite index of physical function,pain, patient global and joint count, RAPID4 (Routine Assessment Of Patient Index Data):Virtually identical results with a patient self-report or physician/assessor joint count or nojoint count in RAPID3. Ann Rheum Dis 2007; 66(Supp II):270.

[31] Pincus T, Sokka T, Yazici Y, Bergman M, and Swearingen CJ. Comparisons of a self-reportRheumatoid Arthritis Disease Activity Index (RADAI) joint count to physician-generated jointcounts and other American College of Rheumatology (ACR) Core Data Set measures forrheumatoid arthritis (RA). Arthritis Rheum 2006; 54(9 Supp):2045.

[30] Pincus T, Bergman M, Yazici Y, and Swearingen CJ. How much does a visual analog scale(VAS) for fatigue add to VAS measures of pain and global estimate? Arthritis Rheum 2006;54(9 Supp):1765.

[29] Pincus T, Bergman M, Yazici Y, Roth J, and Swearingen CJ. Time to score various formats ofa Multi-Dimensional Health Assessment Questionnaire (MDHAQ): Which format would bebest for standard clinical care? Arthritis Rheum 2006; 54(9 Supp):1764.

[28] Pincus T, Yazici Y, Bergman M, Goodin V, Sokka T, and Swearingen CJ. Simplified formats ofvisual analog scales for use in standard rheumatology clinical care: Agreement between a10 cm horizontal line and 21 numbered circles. Arthritis Rheum 2006; 54(9 Supp):768.

[27] Swearingen C and Yazici Y. Low concordance between DAS28 and RAPID, a patient-onlyscale, in a routine care rheumatoid arthritis cohort: What should be the “Gold Standard”?Ann Rheum Dis 2006; 65(Suppl II):608.

[26] Pincus T and Swearingen CJ. Review of systems included on a Multi-Dimensional HAQ(MDHAQ): Utility of a symptom checklist to recognize Fibromyalgia. Ann Rheum Dis 2006;65(Supp II):559.

[25] Pincus T and Swearingen CJ. Variations in MDHAQ scores for physical function, pain,fatigue, and global status are explained more by formal education level than by age orduration of disease in all rheumatic diseases. Ann Rheum Dis 2006; 65(Supp II):598.

[24] Pincus T and Swearingen CJ. Utility of a multi-dimensional health assessment questionnaire(MDHAQ) in all rheumatic diseases. Ann Rheum Dis 2006; 65(Supp II):598.

[23] Pincus T and Swearingen CJ. Quantitative clinical rheumatology: A 5 point scale for aphysician to record an estimate of prognosis in an individual patient in standard care. AnnRheum Dis 2006; 65(Suppl II):649.

[22] Pincus T and Swearingen CJ. A simple 3 point scale to assess diagnostic certainty instandard rheumatology care: High certainty in about 50%, moderate certainty in about 40%,and little or no certainty in about 10% of individual patients seen by one rheumatologist. AnnRheum Dis 2006; 65(Supp II):649.

[21] Pincus T, Bergman M, Yazici Y, and Swearingen CJ. How much does a visual analog scale(VAS) for fatigue add to VAS measures of pain and global estimate? Arthritis Rheum 2006;54(9 Supp):S704.

[20] Swearingen CJ, Rodgers JK, and Lackland D. Self-reported smoking and related healthbehaviors in South Carolina: A geographic analysis of incidence rates of smoking-attributedcancers. Ann Epi 2005; 15(8):661.

[19] Swearingen C and Yazici Y. DMARD therapy for rheumatoid arthritis (RA) in routine care:Improved outcomes at 6 and 12 months, with more significant results in methotrexatetreated patients. Ann Rheum Dis 2005; 64(Suppl III):S218.

Last Updated: July 16, 2014 23 of 26

[18] Pincus T, Swearingen C, Sokka T, and Wolfe F. Patients who begin anti-TNF therapy instandard clinical care at a U.S. academic rheumatology clinic include only 41% with diseaseactivity score (DAS) of > 5.1, while 63% have a self-report Apgar-like patient score on anindex of physical function, pain, patient global of > 7. Arthritis Rheum 2004; 50:S373.

[17] Yazici Y, Sokka T, Kautianinen H, Swearingen CJ, Kulman I, and Pincus T. Methotrexatediscontinuation is unusual in routine clinical care and rarely due to laboratory abnormalities.Ann Rheum Dis 2004; 63(Supp I):S279.

[16] Pincus T, Swearingen CJ, and Sokka T. 10 activities of daily living (ADL) provide similarinformation to 14 adl on a multi-dimensional health assessment questionnaire (MDHAQ).Ann Rheum Dis 2004; 63(Suppl I):S520.

[15] Pincus T, Swearingen CJ, and Sokka T. Methotrexate results in similar levels of 50%improvement after 6 months as cyclosporine, leflunomide, etanercept and infliximab inroutine clinical care, according to a patient self-report index and Erytrocyte SedimentationRate. Ann Rheum Dis 2004; 63(Suppl I):S266.

[14] Yazici Y, Kulman I, Swearingen CJ, Sokka T, and Pincus T. Methotrexate hepatic toxicity inrheumatoid arthritis patients is unusual. Arthritis Rheum 2003; 48:S322.

[13] Pincus T, Swearingen CJ, and Sokka T. Overcoming “floor effects” in the health assessmentquestionnaire (HAQ) and modified health assessment questionnaire (MHAQ) with newitems. Arthritis Rheum 2003; 48:S402.

[12] Pincus T, Swearingen CJ, and Sokka T. A practical patient self-report multi-dimensionalhealth assessment questionnaire (MDHAQ) which provides scores for functional status,pain, global status, fatigue, and psychological distress, on one side of one page, to be“eyeballed” by a physician in 5 seconds and scored in <30 seconds. Arthritis Rheum 2003;48:S458–S459.

[11] Pincus T, Swearingen CJ, and Sokka T. Methotrexate results in similar levels of 20% and50% responses as cyclosporine, leflunomide, etanercept and infliximab in routine clinicalcare, according to an index of functional status, pain and patient global scores, the 3 CoreData Set measures for rheumatoid arthritis (RA) derived from patient self-reportquestionnaires. Arthritis Rheum 2003; 48:S337.

[10] Pincus T and Swearingen CJ. A multi-dimensional health assessment questionnaire(MDHAQ): Use in routine care of all rheumatic diseases with provision to meet healthservices financial administration data requirements for complex visit. Arthritis Rheum 2001;44(9):S186.

[9] Pincus T, Sokka T, Swearingen CJ, Swearingen T, Daltroy L, and Davis T. Analysis of a rapidestimate of adult literacy in medicine (REALM) and education level in patients withrheumatic diseases. Arthritis Rheum 2000; 43(9):S109.

[8] Pincus T, Wolfe F, Sokka T, Swearingen CJ, Callahan LF, Jordan J, and et al.Gastrointestinal symptoms slightly less frequent in osteoarthritis patients takingacetaminophen than Arthrotec (Diclofenac Na/misoprosotol) while efficacy of arthrotec wassignificantly greater. Gastroenterology 2000; 118(4):A1294.

[7] Pincus T and Swearingen CJ. Do clinical trials in rheumatoid arthritis (RA) select for“non-responder” patients? comparisons of earlier courses of patients with 6 or more versusfewer than 6 swollen or tender joints. Arthritis Rheum 1999; 42:S350.

[6] Pincus T, Swearingen CJ, Hoekstra M, Callahan LF, Cummins P, and Lefkowith J. A surveyconcerning experience of patients with osteoarthritis in use of acetaminophen andnonsteroidal anti-inflammatory drugs. Arthritis Rheum 1998; 41:S88.

[5] Pincus T, Swearingen CJ, Callahan LF, and Wolfe F. Documentation of effective care ofrheumatic diseases in routine clinical care using patient questionnaires. Arthritis Rheum1998; 41:S226.

Last Updated: July 16, 2014 24 of 26

[4] Pincus T, Swearingen CJ, and Callahan LF. Use of a patient self-report questionnaire in acomplete history and differential diagnosis of new patients with rheumatic diseases. ArthritisRheum 1998; 41:S226.

[3] Pincus T, Swearingen CJ, and Callahan LF. Addition of 6 complex activities to a modifiedhealth assessment questionnaire (MHAQ) to overcome “floor effects” in assessment offunctional capacity. Arthritis Rheum 1997; 40:S111.

[2] Pincus T, Swearingen CJ, and Callahan LF. A self-report cognitive symptoms inventory toassess patients with rheumatic diseases: Results in eosinophilia-myalgia syndrome (EMS),fibromyalgia, rheumatoid arthritis (RA), and other rheumatic diseases. Arthritis Rheum1996; 39:S261.

[1] Livengood JM, Parris WCV, Moody L, Wood D, and Swearingen CJ. Integrative versus rotememory in chronic pain patients - implications for a multidisciplinary pain treatment program.Anesthesiology 1994; 81(3A):A1042.

SUBMITTED

[2] Canon S, Shera A, Phan M, Lapicz L, Scheidweiler T, Swearingen CJ, Batchelor L, andHurt R. Autonomic Dysreflexia during urodynamics in children and adolescents with SpinalCord Injury or severe neurologic disease. Submit to J Urol.

[1] Canon S, Recicar J, Head BT, Linam LL, Swearingen CJ, and Maxson T. The utility of initaland follow-up ultrasound reevaluation for blunt renal trauma in children and adolescents.Submit to J Pediatr Urol.

UNDER REVISION

[5] Boateng B, Swearingen CJ, and Blaszak RT. A self-assessment rubric to facilitate theachievement of pediatric milestones: Development, validation and lessons learned.

[4] Irby OK, Prodhan P, Swearingen CJ, and Fiser RT. Unfractionated Heparin activity measuredby Anti-Factor Xa levels predicts the need for ECMO circuit changes: A retrospective pediatricstudy.

[3] Linam WM, Storm EA, Bagwell HB, Shirm SW, Honeycutt M, Swearingen CJ, and Graham J.Barriers and motivators of hand hygiene among healthcare workers in a pediatric emergencydepartment.

[2] Yazici Y, Swearingen CJ, Nadkarni A, Reed DM, Naci H, Fleurence R, and Rosenblatt L.Comparative clinical efficacy and tolerability of biological treatments for early, methotrexatenaive Rheumatoid Arthritis patients.

[1] Zakaria D, Frazier E, Imamura M, Garcia X, Pye S, Knecht KR, Prodhan P, Gossett JR,Swearingen CJ, and Morrow WR. Improved survival while waiting and risk factors for deathin pediatric patients listed for cardiac transplantation.

IN DEVELOPMENT

[6] Fisher PL, Wahl E, Lumpkin CK, and Swearingen CJ9. Sensitivity analysis for two treatmenteffects on tumor growth volume.

[5] Garcia X, Pye S, Swearingen CJ, Prodhan P, and Bhutta AT. Catheter associated bloodstream infections in intracardiac lines.

[4] Kaiser JK and Swearingen CJ. Initial plasma glucose concentrations and nadirs in ELGAN,Preterm, Late Preterm, and Term newborns during the early postnatal period.

9Corresponding Author

Last Updated: July 16, 2014 25 of 26

[3] Kilinc O, Gossett JM, Swearingen CJ, and Ratnasamy C. Do implantation guidelines predictappropriate defibrillator therapy in children?

[2] Mulkey SB, Ou X, Ramakrishnaiah RH, Glasier CM, Swearingen CJ, Melguizo castro MS,Yap V, Schmitz ML, and Bhutta AT. Analysis of White Matter Injury in newborns withCongenital Heart Disease using Tract-Based Spatial Statistics.

[1] Reeves DM, Kaiser KR, Swearingen CJ, Malik S, and Sachdeva R. Echocardiographicparameters associated with spontaneous closure of the Patent Ductus Arteriosus inextremely low birth weight infants.

Last Updated: July 16, 2014 26 of 26